Shaiyna Arya
Cell Therapy And Clinical Research Lead @ Eli Lilly and Company
About Shaiyna Arya
Shaiyna Arya serves as the Cell Therapy and Clinical Research Lead at Eli Lilly and Company, where she has worked since 2022. With a background in clinical research and cell therapy, she has contributed to various organizations, including Novartis Gene Therapies and CUTISS AG, and holds a Master of Science in Chemical and Bioengineering from ETH Zürich.